Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned? [PDF]
BioDrugsAvci AB, Feist E, Burmester GR.
europepmc +1 more source
Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents. [PDF]
J Inflamm Res, 2023 Zhao X +7 more
europepmc +1 more source
Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease. [PDF]
EBioMedicinede Ruiter SC +9 more
europepmc +2 more sources
From joints to vessels: How rheumatoid arthritis therapy alters the fate of the heart. [PDF]
World J CardiolZotova LA, Enenkov NV.
europepmc +1 more source
Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis? [PDF]
Exp Biol Med (Maywood), 2022 Liu JM, Chi J.
europepmc +1 more source
Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. [PDF]
Biomolecules, 2021 Pum A, Ennemoser M, Adage T, Kungl AJ.
europepmc +1 more source
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. [PDF]
Acta Histochem, 2022 Rasmi Y +7 more
europepmc +1 more source
Clinical Use of Interleukin-6 Blockade in Neuroimmunological Disorders. [PDF]
Noro Psikiyatr ArsErdal M +4 more
europepmc +1 more source
Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice? [PDF]
Dokl Biochem Biophys, 2023 Amirdzhanova VN +11 more
europepmc +1 more source